SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tidal Trust II - Defiance Daily Target 2X Long HIMS ETF

Defiance Daily Target 2X Long HIMS ETF

Defiance Daily Target 2X Long HIMS ETF ($HIMZ) is trending as traders discuss potential bounce plays and rebounds, with some expressing bullish sentiment. Community members are actively analyzing technical indicators and potential support levels for entry points, while also weighing the impact of $HIMS earnings and JPMorgan Chase's increased ownership. Some traders are discussing using $HIMZ to play swings and capitalize on the volatility of $HIMS.

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Procter & Gamble Co.

Procter & Gamble is trending as the community discusses its recent price action, potential bottom, and upcoming earnings report. Call options activity and LEAPS are being highlighted, while some traders debate the stock's valuation and potential for a run-up. Additionally, some analysts are weighing in with price target adjustments.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain and as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin (XCN) is trending amid mixed community sentiment, with some users expressing frustration over recent price action and labeling it a "scam coin." However, others point to upcoming catalysts like the Goliath mainnet launch and growing holder numbers, suggesting potential for future growth and real-world utility, particularly in the institutional finance sector.

BlackRock Institutional Trust Company N.A. - iShares Russell 1000 Growth ETF

iShares Russell 1000 Growth ETF

IWF is trending amid discussions about growth versus value stocks and potential rotations in market leadership. Options activity suggests some investors anticipate continued upside, while others are hedging against potential declines. Community members are analyzing technical indicators and ETF flows to gauge the strength and direction of the Russell 1000 Growth ETF.

Southwest Airlines Co. engages in the operation and management of a passenger airline. The firm also offers ancillary services such as early bird check-in, upgraded boarding, and transportation of pets and unaccompanied minors. It operates in the United States, the Commonwealth of Puerto Rico, Mexico, Jamaica, the Bahamas, Aruba, Dominican Republic, Costa Rica, Belize, Cuba, the Cayman Islands, and Turks and Caicos. The company was founded by Rollin W. King and Herbert D. Kelleher on March 9, 1967 and is headquartered in Dallas, TX.

Southwest Airlines Co

Southwest Airlines is trending due to a mix of reactions to announced policy changes, including the introduction of baggage fees and a basic economy fare, intended to boost revenue under pressure from activist investor Elliott Management. While some investors are optimistic about the potential for increased profitability, the community is concerned about the impact on customer loyalty and brand perception as Southwest moves away from its traditional value proposition.

UWM Holdings Corp. is a wholesale mortgage lender, which underwrites and provides closing documentation for residential mortgage loans originated by independent mortgage brokers, correspondents, small banks and local credit unions. The firm provides independent mortgage advisors with a set of technologically driven tools and a value proposition that enables them to offer borrowers that meet the credit rating standards compelling financing alternatives. The company was founded in 1986 and is headquartered in Pontiac, MI.

UWM Holdings Corporation - Ordinary Shares - Class A

UWMC is trending as investors discuss its potential amid fluctuating interest rates and compare its valuation to competitors like RKT. Community members are debating the impact of potential Fed rate cuts, the sustainability of its high dividend yield, and CEO Mat Ishbia's stock sales. Some see a refi boom on the horizon, while others express concern over the company's debt and the overall market environment.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana is trending amidst discussions about its valuation, Medicare Advantage plans, and potential partnerships, particularly with Clover Health. The stock's volatile price action and perceived manipulation are also key talking points among investors. Some analysts suggest the recent pullback is an overreaction and highlight the company's long-term potential and attractive entry points.

ARK Investment Management LLC - ARK Innovation ETF

ARK Innovation ETF

ARKK is trending as investors assess its recent performance and potential for future growth amid discussions around innovation and disruptive technologies. The ETF's holdings, including TSLA, and potential investment strategies are key talking points. Community members are weighing the fund's long-term outlook and debating whether it represents a trading or investment opportunity.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is trending as the community discusses recent legal developments, including a $966 million verdict in a talc-related cancer case and a potential link between Tylenol and autism, which has drawn attention from influential figures. Traders are weighing the potential impact of these issues alongside the company's financials, pipeline updates, and strategic moves like the potential spin-off of its orthopedics business, as well as potential acquisitions of other pharmaceutical companies to offset revenues.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics is trending as traders discuss the stock's potential bottom and speculate on a sharp upward move if a golden cross forms on the daily chart. News regarding the completion of enrollment in its Phase 2 LOTUS trial for Hidradenitis Suppurativa has sparked interest, though topline data isn't expected until mid-2026. Bullish analysts maintain high price targets, and the community is actively trading options, anticipating a significant return on investment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

First Trust Exchange-Traded Fund VIII - FT Vest U.S. Equity Buffer ETF - September

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Palantir Technologies Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$51.05
Prev Close	$51.00
Open	$51.20
Dividend Yield	N/A
50-Day Moving Average	$50.38
Beta	N/A
Avg. Volume	114,236.38
PE Ratio	N/A

52-Week High	$51.45
52-Week Low	$40.34
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

FSEP
First Trust Exchange-Traded Fund VIII - FT Cboe Vest U.S. Equity Buffer ETF -September

Feed

News

Sentiment

Fundamentals

Info

Latest FSEP News

FSEPFirst Trust Exchange-Traded Fund VIII - FT Cboe Vest U.S. Equity Buffer ETF -September